Back to EYPT

EyePoint Pharmaceuticals, Inc. 8-K

Accession 0001193125-14-402160

Filing information

CIK
0001314102
Report date
2014-11-07
Filing date
2014-11-07
Form
8-K
Primary document
d815926d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.